DocGo Inc. Files 8-K for Regulation FD Disclosure

TL;DR

DocGo filed a standard 8-K on 12/20/24, no major news.

AI Summary

DocGo Inc. filed an 8-K on December 20, 2024, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events beyond the standard reporting requirement for this date. The company previously operated as Motion Acquisition Corp. before changing its name on August 24, 2020.

Why It Matters

This filing indicates DocGo Inc. is adhering to regulatory disclosure requirements. Investors should review the full filing for any specific details that may impact the company's operations or stock.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for a Regulation FD Disclosure and does not contain new material information or significant financial events.

Key Players & Entities

• DocGo Inc. (company) — Registrant
• Motion Acquisition Corp. (company) — Former company name
• December 20, 2024 (date) — Date of report
• August 24, 2020 (date) — Date of name change

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 per share DCGO The Nasdaq Stock Market
• $26 million — Program, the Company may purchase up to $26 million in shares of the Company's common stock

Filing Documents

• dcgo-20241220.htm (8-K) — 28KB
• 0001822359-24-000119.txt ( ) — 151KB
• dcgo-20241220.xsd (EX-101.SCH) — 2KB
• dcgo-20241220_lab.xml (EX-101.LAB) — 22KB
• dcgo-20241220_pre.xml (EX-101.PRE) — 13KB
• dcgo-20241220_htm.xml (XML) — 3KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On December 20, 2024, the Board of Directors of DocGo Inc. (the "Company") approved an extension of the expiration date of the Company's current share repurchase program ("Repurchase Program") from December 31, 2024 to June 30, 2025. As previously disclosed, pursuant to the Repurchase Program, the Company may purchase up to $26 million in shares of the Company's common stock. Other than the extension of the program's expiration date, no changes were made to the Repurchase Program. Under the terms of the Repurchase Program, as extended, the Company may continue to purchase shares of its common stock on a discretionary basis from time to time through open market repurchases or privately negotiated transactions or through other means, including by entering into Rule 10b5-1 trading plans or accelerated share repurchase programs, in each case, during an "open window" and when the Company does not possess material non-public information. The timing and actual number of shares repurchased under the Repurchase Program will depend on a variety of factors, including stock price, trading volume, market conditions, corporate and regulatory requirements and other general business considerations. The Repurchase Program may be modified, suspended or discontinued at any time without prior notice. Repurchases under the Repurchase Program may be funded from the Company's existing cash and cash equivalents, future cash flow or proceeds of borrowings or debt offerings. The information in Item 7.01 of this Current Report is being furnished and shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing. 1 SIGNATURE Pursuant to the requirements of

View Full Filing

View this 8-K filing on SEC EDGAR